Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor de Ledinghen

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Clinics and Research in Hepatology and Gastroenterology|April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic responseJessica Azzi, Céline Dorival, Carole Cagnot, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2022
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysisGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|October 5, 2023
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteriaGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
The American Journal of Gastroenterology|June 7, 2019
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver DiseaseSalvatore Petta, Vincent Wai-Sun Wong, Elisabetta Bugianesi, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 14, 2017
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version)Christoph F Dietrich, Jeffrey Bamber, Annalisa Berzigotti, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 4, 2018
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)Christoph F Dietrich, Jeffrey Bamber, Annalisa Berzigotti, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 14, 2017
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)Christoph F Dietrich, Jeffrey Bamber, Annalisa Berzigotti, et al.
Journal of Hepatology|December 11, 2020
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver diseaseMargarita Papatheodoridi, Jean Baptiste Hiriart, Monica Lupsor-Platon, et al.
Journal of Hepatology|February 24, 2015
Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-respondersDonald Jensen, Kenneth E Sherman, Christophe Hézode, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2020
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver DiseaseSalvatore Petta, Giada Sebastiani, Mauro Viganò, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Clinics and Research in Hepatology and Gastroenterology|April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic responseJessica Azzi, Céline Dorival, Carole Cagnot, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2022
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysisGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|October 5, 2023
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteriaGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
The American Journal of Gastroenterology|June 7, 2019
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver DiseaseSalvatore Petta, Vincent Wai-Sun Wong, Elisabetta Bugianesi, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 14, 2017
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version)Christoph F Dietrich, Jeffrey Bamber, Annalisa Berzigotti, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 4, 2018
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)Christoph F Dietrich, Jeffrey Bamber, Annalisa Berzigotti, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 14, 2017
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)Christoph F Dietrich, Jeffrey Bamber, Annalisa Berzigotti, et al.
Journal of Hepatology|December 11, 2020
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver diseaseMargarita Papatheodoridi, Jean Baptiste Hiriart, Monica Lupsor-Platon, et al.
Journal of Hepatology|February 24, 2015
Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-respondersDonald Jensen, Kenneth E Sherman, Christophe Hézode, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2020
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver DiseaseSalvatore Petta, Giada Sebastiani, Mauro Viganò, et al.
Pageof 18